These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 29610020)
1. Pharmacological treatment of gastrointestinal bleeding due to angiodysplasias: A position paper of the Italian Society of Gastroenterology (SIGE). Nardone G; Compare D; Martino A; Rocco A Dig Liver Dis; 2018 Jun; 50(6):542-548. PubMed ID: 29610020 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic failure with thalidomide in patients with recurrent intestinal bleeding due to angiodysplasias. Izquierdo Navarro Mdel C; Hernando Verdugo M; Cardaba Garcia E; Sanchez Sanchez MT Farm Hosp; 2016 May; 40(3):230-2. PubMed ID: 27145393 [TBL] [Abstract][Full Text] [Related]
3. Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed? Molina-Infante J; Perez-Gallardo B Dig Dis Sci; 2011 Jan; 56(1):266-7. PubMed ID: 21046246 [No Abstract] [Full Text] [Related]
4. Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia. Bon C; Aparicio T; Vincent M; Mavros M; Bejou B; Raynaud JJ; Zampeli E; Airinei G; Sautereau D; Benamouzig R; Michopoulos S Aliment Pharmacol Ther; 2012 Sep; 36(6):587-93. PubMed ID: 22831465 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis. Goltstein LCMJ; Grooteman KV; Rocco A; Holleran G; Frago S; Salgueiro PS; Aparicio T; Scaglione G; Chetcuti Zammit S; Prados-Manzano R; Benamouzig R; Nardone G; McNamara D; Benallaoua M; Michopoulos S; Sidhu R; Kievit W; Drenth JPH; van Geenen EJM Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):922-932. PubMed ID: 34508668 [TBL] [Abstract][Full Text] [Related]
6. [Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias]. de Koning DB; Drenth JP; Friederich P; Nagengast FM Ned Tijdschr Geneeskd; 2006 Sep; 150(36):1994-7. PubMed ID: 17002190 [TBL] [Abstract][Full Text] [Related]
7. Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias. Garrido A; Sayago M; López J; León R; Bellido F; Márquez JL Rev Esp Enferm Dig; 2012 Feb; 104(2):69-71. PubMed ID: 22372800 [TBL] [Abstract][Full Text] [Related]
8. Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial. Grooteman KV; van Geenen EJ; Drenth JP BMJ Open; 2016 Sep; 6(9):e011442. PubMed ID: 27619827 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and therapeutic challenges of gastrointestinal angiodysplasias: A critical review and view points. García-Compeán D; Del Cueto-Aguilera ÁN; Jiménez-Rodríguez AR; González-González JA; Maldonado-Garza HJ World J Gastroenterol; 2019 Jun; 25(21):2549-2564. PubMed ID: 31210709 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in the treatment of refractory gastrointestinal angiodysplasia. Becq A; Sidhu R; Goltstein LCMJ; Dray X United European Gastroenterol J; 2024 Oct; 12(8):1128-1135. PubMed ID: 39229890 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias. Dabak V; Kuriakose P; Kamboj G; Shurafa M Dig Dis Sci; 2008 Jun; 53(6):1632-5. PubMed ID: 17990111 [TBL] [Abstract][Full Text] [Related]
12. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases. Nardone G; Compare D; Scarpignato C; Rocco A Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688 [TBL] [Abstract][Full Text] [Related]
14. Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series. Kamalaporn P; Saravanan R; Cirocco M; May G; Kortan P; Kandel G; Marcon N Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1347-50. PubMed ID: 19730385 [TBL] [Abstract][Full Text] [Related]
15. Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations. Bauditz J World J Gastroenterol; 2016 Mar; 22(11):3158-64. PubMed ID: 27003992 [TBL] [Abstract][Full Text] [Related]
17. Long-term results with lanreotide in patients with recurrent gastrointestinal angiodysplasias bleeding or obscure gastrointestinal bleeding. Benefits in efficacy and procedures consumption. Frago S; Alcedo J; Martín Pena-Galo E; Lázaro M; Ollero L; de la Llama N Scand J Gastroenterol; 2018 Dec; 53(12):1496-1502. PubMed ID: 30621520 [TBL] [Abstract][Full Text] [Related]
18. Success of estrogen-progesterone therapy in long-standing bleeding gastrointestinal angiodysplasia. Report of a case. Moshkowitz M; Arber N; Amir N; Gilat T Dis Colon Rectum; 1993 Feb; 36(2):194-6. PubMed ID: 8425426 [TBL] [Abstract][Full Text] [Related]
19. Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide. Bauditz J; Lochs H; Voderholzer W Endoscopy; 2006 Oct; 38(10):1036-9. PubMed ID: 17058171 [TBL] [Abstract][Full Text] [Related]
20. Treatment of multiple small bowel angiodysplasias causing severe life-threatening bleeding with thalidomide. Kirkham SE; Lindley KJ; Elawad MA; Blanshard C; Shah N J Pediatr Gastroenterol Nutr; 2006 May; 42(5):585-7. PubMed ID: 16707986 [No Abstract] [Full Text] [Related] [Next] [New Search]